全球化学品在线数据库

SDS 文件列表(按CAS登录号排序)

[ 1841081-72-8 ] - [ 1887742-42-8 ]

用户可以点击下表中相应的产品行,浏览或下载 CAS 号在 1841081-72-8 和 1887742-42-8 之间的产品的 SDS 文档样本。点击页面下方的各个CAS 号码分组,可以选择更多的产品。用户也可以使用页面上方的搜索框迅速得到所要查询的产品的 SDS 文档样本。

CAS 登录号 产品名称 分子式
1841081-72-8 1-(2-Ethoxyethyl)-2-(4-piperidinyl)-1H-benzimidazole hydrochloride (1:1) C16H23N3O.HCl
1844894-70-7 Vildagliptin Dione Impurity;(S)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)hexahydropyrrolo[1,2-a]pyrazine-1,4-dione C17H24N2O3
1846558-62-0 [5-[Bis(1,1-dimethylethyl)phosphino-kappap]-1',3',5'-triphenyl-1,4'-BI-1H-pyrazole][(1,2,3-eta)-1-phenyl-2-propen-1-YL]-palladium(1+), 1,1,1-trifluoromethanesulfonate (1:1) C42H42F3N4O3PPdS-4
1848244-75-6 [2',4'-Bis(1,1-dimethylethyl)-6'-methoxy[1,1'-biphenyl]-2-yl]dicyclohexylphosphine C33H49OP
1849590-01-7 6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione C17H20N6O2
1849594-85-9 5-Bromo-1,6-dihydro-3-methyl-6-oxo-2-pyridinecarboxylic acid ethyl ester C9H10BrNO3
1850305-79-1 N-[2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl]carbamic acid 1,1-dimethylethyl ester C13H26BNO4
1850305-80-4 N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)propyl]carbamic acid 1,1-dimethylethyl ester C14H28BNO4
1853997-27-9 2-(4-Bromo-1-naphthalenyl)-1,10-phenanthroline C22H13BrN2
1854067-25-6 (R)-1-[(S)-2-(2'-Diphenyphosphinophenyl)ferrocenyl]ethyldiphenylphosphine C42H31FeP2
1854067-37-0 (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(diphenylphosphino)phenyl]ferrocene;Walphos SL-W012-2 C38H44FeP2
1854067-50-7 (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene;Walphos SL-W029-1 C38H56FeP2
1854067-58-5 (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(dicylohexylphosphino)phenyl]ferrocene;Walphos SL-W029-2 C38H56FeP2
1854067-62-1 (R)-1-[(R)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene;Walphos SL-W030-1 C34H52FeP2
1854067-71-2 (S)-1-[(S)-1-(Di-tert-butylphosphino)ethyl]-2-[2-(di-tertbutylphosphino)phenyl]Ferrocene;Walphos SL-W030-2 C34H52FeP2
1855006-12-0 Regorafenib EP Impurity C;4-(3-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide C20H18FN5O3
1855920-54-5 3-chloro Rivaroxaban;3-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide C19H18ClN3O5S
1859053-21-6 (1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptane-1-methanesulfonic acid compd. with 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one (1:1) C19H18FN3O.C10H16O4S
1859162-80-3 Sofosbuvir Impurity 93;[(2R,3R,4R,5R)-5-(2,4-dioxo-1,3-diazinan-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methyl phenyl hydrogen phosphate C16H20FN2O8P
1860012-45-8 tert-Butyl N-[(2S,3S)-2-methylpiperidin-3-yl]carbamate C11H22N2O2
1860012-52-7 (3R,5S)-3-Amino-5-methyl-1-piperidinecarboxylic acid 1,1-dimethylethyl ester C11H22N2O2
1860793-92-5 Hexahydro-6-(phenylmethyl)-pyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione C14H17N3O2
1862216-82-7 Ethyl 9-phenyl-9H-carbazole-3-carboxylate C21H17NO2
1863098-74-1 Cyclopropyl(4,6-dichloropyridin-3-yl)methanonethanone C9H7Cl2NO
1863930-34-0 Azilsartan Impurity F;ethyl 3-amino-2-[[4-(2-carbamoylphenyl)phenyl]methylamino]benzoate C23H23N3O3
1864897-67-5 2-Hydroxy-N-(pyridin-4-yl)butanamide C9H12N2O2
1868064-50-9 Abiraterone Acetate 5,6-Epoxide;[(1S,2R,5S,7R,9S,11S,12S,16S)-2,16-dimethyl-15-pyridin-3-yl-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-14-en-5-yl] acetate C26H33NO3
1868232-32-9 (R)-N-Cyclohexyl-3-[(3,4-dichlorophenethyl)amino]-N-[2-[[2-hydroxy-2-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethyl]amino]ethyl]propanamide C29H38Cl2N4O4
1869075-89-7 Bendamustine USP Related Compound F;[(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl] 4-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]butanoate C22H33Cl2N3O7
1869118-24-0 N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester;ethyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate C16H16N4O4S
1870821-29-6 (S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline C16H14BrCl2N
1872382-47-2 N-[4-(1,1-Dimethylethyl)benzoyl]-L-phenylalanyl-L-alanyl-L-leucyl-N6,N6-diethyl-L-lysyl-L-serine methyl ester C43H66N6O8
1872435-00-1 Leuprolide Acetate EP Impurity F;N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide;2,2,2-trifluoroacetic acid C61H85F3N16O14
1874276-76-2 3-Amino-N-[3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl]-6-[3-(trifluoromethyl)pyridin-2-yl]pyrazine-2-carboxamide C22H23F3N8O
1876467-74-1 2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine C20H21N7O
1878105-23-7 N-XantPhos Pd G4;(SP-4-4)-[4-(Diphenylphosphino-?P)-6-(diphenylphosphino)-10H-phenoxazine](methanesulfonato-?O)[2'-(methylamino-?N)[1,1'-biphenyl]-2-yl-?C]palladium C50H43N2O4P2PdS-
1882873-21-3 Lenvatinib Impurity 16;1-[2-chloro-4-(6-cyano-7-methoxyquinolin-4-yl)oxyphenyl]-3-cyclopropylurea C21H17ClN4O3
1883265-36-8 2-([1,1'-Biphenyl]-3-yl)-4-chloro-6-(dibenzo[b,d]furan-1-yl)-1,3,5-triazine C27H16ClN3O
1883299-62-4 Brepocitinib;[(1S)-2,2-difluorocyclopropyl]-[(1R,5S)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-3,8-diazabicyclo[3.2.1]octan-8-yl]methanone C18H21F2N7O
1883377-30-7 8-[4-(2,2-Dimethylpropyl)-2-pyridinyl]-2-(methyl)-benzofuro[2,3-b]pyridine C22H22N2O
1883423-59-3 [(2S)-2-(4-Chlorophenyl)-1-pyrrolidinyl](3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)methanone C18H17ClN4O
1883429-22-8 4-(4-((Dimethylamino)methyl)-2,5-dimethoxyphenyl)-2-methyl-2,7-naphthyridin-1(2H)-one;BI 9564 C20H23N3O3
1883563-86-7 Tenofovir Related Compound 8;methane;propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-[[(2S)-1-oxo-1-propan-2-yloxypropan-2-yl]amino]phosphoryl]amino]propanoate C22H40N7O6P
1883595-38-7 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxylic acid C11H8FNO2
1883681-10-4 Azilsartan Impurity 21;3-Hydroxy-2-oxobutyl azilsartan ester C29H26N4O7
1887009-48-4 (S)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride;3-[(1S)-1-aminoethyl]-6-chloro-1H-quinolin-2-one;hydrochloride C11H12Cl2N2O
1887009-51-9 (R)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one hydrochloride C11H12Cl2N2O
1887015-55-5 5-Fluoro-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile C7H5FN2O
1887057-05-7 Docetaxel EP Impurity A;2-O-desbenzoyl-2-O-tiglyldocetaxel C41H55NO14
1887742-42-8 Adb-fubinaca metabolite M3;N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1H-indazole-3-carboxamide C14H18N4O2

浏览其它 SDS 列表
1481631-51-9 to 1517611-20-9   1522098-73-2 to 1547492-13-6   1548450-59-4 to 1594127-49-7   1596367-55-3 to 1611493-60-7   1612153-32-8 to 1627091-47-7   1627494-13-6 to 1638759-79-1   1638763-87-7 to 1665195-94-7   1665288-66-3 to 1702259-66-2   1702271-98-4 to 1788054-69-2   1788054-91-0 to 1801267-04-8   1801421-10-2 to 1807941-46-3   1808248-05-6 to 1840966-49-5   1888294-91-4 to 1951441-43-2   1951483-29-6 to 2044709-88-6   2044710-35-0 to 2089314-64-5   2089321-22-0 to 2136287-66-4   2137722-14-4 to 2177287-68-0   2183475-72-9 to 2230200-74-3   2230200-76-5 to 2271411-87-9   2276678-27-2 to 2380230-73-7   2381400-91-3 to 2484719-11-9   2484719-14-2 to 2731228-51-4   2732926-26-8 to 2971088-37-4